# Glutaminergic Agents for Cocaine Abuse - 5

> **NCT00000280** · PHASE1 · COMPLETED · sponsor: **Yale University**

## Conditions studied

- Cocaine-Related Disorders

## Interventions

- **DRUG:** Nimodipine

## Key facts

- **NCT ID:** NCT00000280
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1994-09
- **Primary completion:** 1999-08
- **Final completion:** 1999-08
- **Target enrollment:** 0 (—)
- **Last updated:** 2017-04-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000280

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000280, "Glutaminergic Agents for Cocaine Abuse - 5". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT00000280. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*